000 | 01998 a2200625 4500 | ||
---|---|---|---|
005 | 20250517133152.0 | ||
264 | 0 | _c20170823 | |
008 | 201708s 0 0 eng d | ||
022 | _a1528-0020 | ||
024 | 7 |
_a10.1182/blood-2016-08-737163 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aChauvet, Sophie | |
245 | 0 | 0 |
_aTreatment of B-cell disorder improves renal outcome of patients with monoclonal gammopathy-associated C3 glomerulopathy. _h[electronic resource] |
260 |
_bBlood _c03 2017 |
||
300 |
_a1437-1447 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 | _aAged, 80 and over |
650 | 0 | 4 |
_aB-Lymphocytes _xpathology |
650 | 0 | 4 | _aCohort Studies |
650 | 0 | 4 |
_aComplement C3 _xanalysis |
650 | 0 | 4 | _aDatabases, Factual |
650 | 0 | 4 |
_aDrug Therapy _xmethods |
650 | 0 | 4 | _aFrance |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aKidney Diseases _xdrug therapy |
650 | 0 | 4 |
_aKidney Glomerulus _xpathology |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aMolecular Targeted Therapy |
650 | 0 | 4 |
_aParaproteinemias _xcomplications |
650 | 0 | 4 | _aRetrospective Studies |
650 | 0 | 4 | _aTreatment Outcome |
650 | 0 | 4 | _aYoung Adult |
700 | 1 | _aFrémeaux-Bacchi, Véronique | |
700 | 1 | _aPetitprez, Florent | |
700 | 1 | _aKarras, Alexandre | |
700 | 1 | _aDaniel, Laurent | |
700 | 1 | _aBurtey, Stéphane | |
700 | 1 | _aChoukroun, Gabriel | |
700 | 1 | _aDelmas, Yahsou | |
700 | 1 | _aGuerrot, Dominique | |
700 | 1 | _aFrançois, Arnaud | |
700 | 1 | _aLe Quintrec, Moglie | |
700 | 1 | _aJavaugue, Vincent | |
700 | 1 | _aRibes, David | |
700 | 1 | _aVrigneaud, Laurence | |
700 | 1 | _aArnulf, Bertrand | |
700 | 1 | _aGoujon, Jean Michel | |
700 | 1 | _aRonco, Pierre | |
700 | 1 | _aTouchard, Guy | |
700 | 1 | _aBridoux, Frank | |
773 | 0 |
_tBlood _gvol. 129 _gno. 11 _gp. 1437-1447 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1182/blood-2016-08-737163 _zAvailable from publisher's website |
999 |
_c26767658 _d26767658 |